**Core Concept:** Chromosomal translocations are genetic abnormalities that occur when portions of chromosomes break off and rearrange, leading to the fusion of two separate genes into one. In Chronic Myeloid Leukemia (CML), a specific type of chromosomal translocation is responsible for the disease.

**Why the Correct Answer is Right:** In Chronic Myeloid Leukemia, the correct answer refers to the Philadelphia chromosome, a characteristic genetic abnormality. This chromosome results from a reciprocal translocation between chromosomes 9 and 22, specifically t(9;22)(q34;q11). The fusion of two genes, BCR (breakpoint cluster region) and ABL1 (Abelson murine leukemia viral oncogene homolog 1), results in the production of a constitutively active tyrosine kinase enzyme, BCR-ABL. This enzyme exerts a sustained proliferative signal, causing uncontrolled division of hematopoietic stem cells and leading to the development of CML.

**Why Each Wrong Option is Incorrect:**

A. This option refers to a different chromosomal translocation, which is not the Philadelphia chromosome found in CML.
B. This answer does not mention the specific chromosomal translocation (t(9;22)) associated with CML.
C. This option is incorrect as it refers to a different genetic abnormality not related to CML.
D. This answer does not mention the specific fusion gene (BCR-ABL) responsible for the constitutively active tyrosine kinase enzyme in CML.

**Clinical Pearl:** The Philadelphia chromosome and BCR-ABL gene fusion are essential for understanding the pathogenesis of Chronic Myeloid Leukemia and distinguishing it from other types of leukemia or myeloproliferative disorders. This knowledge is crucial for appropriate diagnosis, prognosis, and treatment decisions in clinical practice.